Positive News SentimentPositive NewsNASDAQ:MLAB Mesa Laboratories (MLAB) Stock Price, News & Analysis $97.77 +0.27 (+0.28%) Closing price 04:00 PM EasternExtended Trading$97.71 -0.06 (-0.06%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Mesa Laboratories Stock (NASDAQ:MLAB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Mesa Laboratories alerts:Sign Up Key Stats Today's Range$95.86▼$98.5250-Day Range$90.80▼$109.1352-Week Range$55.45▼$113.99Volume92,260 shsAverage Volume147,812 shsMarket Capitalization$547.12 millionP/E Ratio81.48Dividend Yield0.65%Price Target$94.00Consensus RatingReduce Company Overview Mesa Laboratories, Inc. (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes. The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications. Mesa Laboratories also offers calibration standards, software platforms and technical support services that enable clients to maintain accurate instrument performance and fulfill industry-specific quality assurance requirements. Since its founding in 1968, Mesa Laboratories has expanded through a combination of in-house research and development and strategic acquisitions to broaden its instrumentation offerings and geographic reach. The company maintains manufacturing and service facilities across North America, Europe and the Asia-Pacific region, leveraging a global distribution network to deliver products and support to customers in more than 100 countries.AI Generated. May Contain Errors. Read More Mesa Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks26th Percentile Overall ScoreMLAB MarketRank™: Mesa Laboratories scored higher than 26% of companies evaluated by MarketBeat, and ranked 744th out of 834 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingReduce Consensus RatingMesa Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Mesa Laboratories is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageMesa Laboratories has only been the subject of 1 research reports in the past 90 days.Read more about Mesa Laboratories' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Mesa Laboratories is 80.84, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 40.04.Price to Earnings Ratio vs. SectorThe P/E ratio of Mesa Laboratories is 80.84, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.14.Price to Book Value per Share RatioMesa Laboratories has a P/B Ratio of 2.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Mesa Laboratories' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.22% of the float of Mesa Laboratories has been sold short.Short Interest Ratio / Days to CoverMesa Laboratories has a short interest ratio ("days to cover") of 1.21, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mesa Laboratories has recently decreased by 0.72%, indicating that investor sentiment is improving. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldMesa Laboratories has a dividend yield of 0.63%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthMesa Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Mesa Laboratories is 53.33%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Mesa Laboratories' dividend. News and Social Media4.2 / 5News Sentiment1.73 News SentimentMesa Laboratories has a news sentiment score of 1.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.92 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Mesa Laboratories this week, compared to 1 article on an average week.Search Interest2 people have searched for MLAB on MarketBeat in the last 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $770,122.00 in company stock.Percentage Held by Insiders4.90% of the stock of Mesa Laboratories is held by insiders.Percentage Held by Institutions90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Mesa Laboratories' insider trading history. Receive MLAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MLAB Stock News HeadlinesMesa Laboratories declares $0.16 dividendJuly 6, 2026 | seekingalpha.comMESA LABS DECLARES QUARTERLY DIVIDENDJuly 6, 2026 | globenewswire.comTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.July 27 at 1:00 AM | Altimetry (Ad)Mesa Laboratories Executives Quietly Unload Significant Stock HoldingsJune 17, 2026 | tipranks.comMesa Laboratories Promotes Lyndsey Crennen to Chief Accounting OfficerJune 15, 2026 | tipranks.comMesa Laboratories Confronts Rising Cyber Resilience Compliance Risks Under EU CRA Ahead of 2026 DeadlinesJune 4, 2026 | tipranks.comWhy Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off TodayMay 27, 2026 | fool.comMesa Labs Announces Fourth Quarter and Fiscal Year 2026 ResultsMay 27, 2026 | globenewswire.comSee More Headlines MLAB Stock Analysis - Frequently Asked Questions How have MLAB shares performed this year? Mesa Laboratories' stock was trading at $78.50 at the beginning of the year. Since then, MLAB shares have increased by 24.1% and is now trading at $97.4250. How were Mesa Laboratories' earnings last quarter? Mesa Laboratories, Inc. (NASDAQ:MLAB) released its earnings results on Wednesday, May, 27th. The medical instruments supplier reported $1.53 EPS for the quarter, missing the consensus estimate of $1.78 by $0.25. The medical instruments supplier had revenue of $63.72 million for the quarter, compared to analysts' expectations of $65.21 million. Mesa Laboratories had a trailing twelve-month return on equity of 20.96% and a net margin of 2.69%. Who are Mesa Laboratories' major shareholders? Top institutional shareholders of Mesa Laboratories include Wasatch Advisors LP (2.10%). Insiders that own company stock include John Bradley Schmieder, Gary M Owens, John Sakys, Shiraz Shabanali Ladiwala, Brian David Archbold, R Tony Tripeny, Mark Christopher Capone and Lyndsey Elizabeth Crennen. View institutional ownership trends. How do I buy shares of Mesa Laboratories? Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Mesa Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings5/27/2026Record date for 6/15 Dividend5/29/2026Ex-Dividend for 6/15 Dividend5/29/2026Dividend Payable6/15/2026Today7/27/2026Next Earnings (Estimated)8/10/2026Record date for 9/15 Dividend8/31/2026Ex-Dividend for 9/15 Dividend8/31/2026Dividend Payable9/15/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 MLAB's financial health is in the Green zone, according to TradeSmith. MLAB has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryElectronic Equipment & Instruments Current SymbolNASDAQ:MLAB CIK724004 Webwww.mesalabs.com Phone(303) 987-8000Fax303-987-8989Employees680Year Founded1982Price Target and Rating Average Price Target for Mesa Laboratories$94.00 High Price Target$94.00 Low Price Target$94.00 Potential Upside/Downside-3.9%Consensus RatingReduce Rating Score (0-4)1.67 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$1.20 Trailing P/E Ratio81.48 Forward P/E RatioN/A P/E GrowthN/ANet Income$6.71 million Net Margins2.69% Pretax Margin4.82% Return on Equity20.96% Return on Assets8.78% Debt Debt-to-Equity Ratio0.78 Current Ratio1.72 Quick Ratio1.29 Sales & Book Value Annual Sales$249.13 million Price / Sales2.20 Cash Flow$11.81 per share Price / Cash Flow8.28 Book Value$33.71 per share Price / Book2.90Miscellaneous Outstanding Shares5,596,000Free Float5,439,000Market Cap$547.12 million OptionableNot Optionable Beta0.93 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:MLAB) was last updated on 7/27/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThree oil giants buried the same discovery for 50 yearsIn 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesa Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
